Cyproheptadine (Compound)

Synonyms:CYPROHEPTADINE, 129-03-3, Periactin, Eiproheptadine, Periactinol, Dronactin, 4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine, Ciproheptadina, Cyproheptadinum, Periactine, Peritol, Ciprovit, MK 141, 4-(5H-Dibenzo(a,d)cyclohepten-5-ylidene)-1-methylpiperidine, 1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine, 5-(1-Methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene, 1-Methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine, 4-(5-Dibenzo(a,d)cyclohepten-5-ylidine)-1-methylpiperidine, Cyproheptadine (INN), 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-methylpiperidine, CHEMBL516, Piperidine, 4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-methyl-, Piperidine, 4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-methyl-, 2YHB6175DO, CHEBI:4046, Cypoheptadine, Cyproheptadiene, DTXSID8022872, 1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine, 1-Methyl-4-(5H-dibenzo[a,d]cycloheptenylidene)piperidine, NCGC00015252-08, 41354-29-4, CYPROHEPTADINE [INN], Cyproheptadine [INN:BAN], DTXCID702872, Cyproheptadinum [INN-Latin], 4-Dibenzo[a,d]cyclohepten-5-ylidene-1-methyl-piperidine, Ciproheptadina [INN-Spanish], Ciprovit (TN), CAS-129-03-3, CCRIS 5232, HSDB 3048, EINECS 204-928-9, BRN 1685976, cyproheptidine, UNII-2YHB6175DO, Reactin, 4-(5H-Dibenzo(a,d)cyclohepten-5-ylidene)-1-methylpiperidene, Peritol (Salt/Mix), Tocris-0996, Prestwick0_000103, Prestwick1_000103, Prestwick2_000103, Prestwick3_000103, Lopac-C-6022, Biomol-NT_000131, CYPROHEPTADINE [MI], SCHEMBL4021, Lopac0_000246, Oprea1_498140, BSPBio_000086, CYPROHEPTADINE [HSDB], GTPL277, 5-20-08-00500 (Beilstein Handbook Reference), BIDD:GT0324, CYPROHEPTADINE [VANDF], SPBio_002025, BPBio1_000096, BPBio1_000155, CYPROHEPTADINE [WHO-DD], HMS2090P20, HY-B1622, Tox21_110112, BBL010977, BDBM50017721, DL-136, MFCD00242817, PDSP1_001229, PDSP2_001213, STK802098, AKOS004119847, Tox21_110112_1, CCG-204341, DB00434, SDCCGSBI-0050234.P003, NCGC00015252-01, NCGC00015252-02, NCGC00015252-03, NCGC00015252-04, NCGC00015252-05, NCGC00015252-06, NCGC00015252-07, NCGC00015252-09, NCGC00015252-10, NCGC00015252-12, NCGC00015252-13, NCGC00015252-26, NCGC00024293-02, NCGC00024293-04, NCGC00024293-05, CAS-969-33-5, VS-02784, SBI-0050234.P002, DB-041917, CS-0013555, FT-0631755, C06935, D07765, A915360, EN300-18552723, L001016, Q417884, BRD-K28143534-001-01-4, BRD-K28143534-001-03-0, BRD-K28143534-003-03-6, BRD-K28143534-003-14-3, 4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidinehydrochloride, 4-(dibenzo[[?],[?]][7]annulen-11-ylidene)-1-methyl-piperidine, 4-(Dibenzo[1,2-A:2',1'-D][7]annulen-11-Ylidene)-1-Methyl-Piperidine, 1-methyl-4-(2-tricyclo[9.4.0.0^{3,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine, 1-methyl-4-{tricyclo[9.4.0.0(3),?]pentadeca-1(11),3,5,7,9,12,14-heptaen-2-ylidene}piperidine, 1-methyl-4-{tricyclo[9.4.0.0,3,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-ylidene}piperidine, 1-methyl-4-{tricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-ylidene}piperidine, 1-methyl-4-{tricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,9,11,13-heptaen-2-ylidene}piperidine, 4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-methylpiperidine
Pubchem:PUBCHEM:2913
Id:458cc64f-db4d-50ba-87af-698156df852c
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Cyproheptadine's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Cyproheptadine.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Cyproheptadine.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.